MS registry in Germany - Results of the pilot phase;MS-register in Deutschland: Abschließende ergebnisse der pilotphase

Neurologie und Rehabilitation

Volumn 13, Issue 4, 2007, Pages 193-200

  Flachenecker, P ^a,b,k   Zettl, U K ^c   Gotze U ^d   Stuke, K ^d,j   Elias, W ^e   Eulitz, M ^f   Haas, J ^g   Pette, M ^f   Pitschnau Michel, D ^h   Schimrigk, S ⁱ   Rieckmann, P ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^b Neurol Rehabilitationszentrum Quellenhof Bad Wildbad

^c UNIVERSITY OF ROSTOCK   (Germany)

^d MS Forschungs und Projektentwicklungs gGmbH Hannover

^e Neurol Schwerpunktpraxis Hamburg   (Germany)

^f UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^g Judisches Krankenhaus Berlin   (Germany)

^h DMSG Bundesverband e V Hannover

ⁱ ST JOSEF HOSPITAL   (Germany)

^j MS Forschungs und Projektentwicklungs gGmbH   (Germany)

^k Neurologisches Rehabilitationszentrum Quellenhof   (Germany)

more..

Author keywords

Database mangagement systems; Drug therapy; Epidemiology; MS register; Multiple sclerosis; Work

Indexed keywords

ARTICLE; DEMOGRAPHY; GERMANY; GROUPS BY AGE; HEALTH CARE; HUMAN; IMMUNOMODULATION; IMMUNOTHERAPY; MULTIPLE SCLEROSIS; PHYSICAL DISABILITY; QUALITY OF LIFE; SEX DIFFERENCE; SOCIAL ASPECT;

EID: 35148846581     PISSN: 09472177     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Confavreux C, Vukusic S, Moreau T, Adeleine P: Relapses and progression of disability in multiple sclerosis. N Engl J Med 2000; 343: 1430-1438
2. Flachenecker P, Zettl UK: Epidemiologic. In: Schmidt RM, Hoffmann F (eds): Multiple Sklerose. Urban & Fischer, München 2006, 11-17
3. Flachenecker P, Zettl UK: Krankheitsverlauf und Prognose. In: Schmidt RM, Hoffmann F (eds): Multiple Sklerose. Urban & Fischer, München 2006, 61-70
4. Flachenecker P, Zettl UK, Götze U, et al: MS Register in Deutschland - Design und erste Ergebnisse der Pilotphase. Nervenarzt 2005; 76: 967-975
5. Haas J, Kugler J, Nippert I, Pöhlau D, Scherer P: Lebensqualität bei Multipler Sklerose. Berliner DMSG-Studie. de Gruyter, Berlin 2003
6. ISIS Research plc: MS Therapy Monitors, 2004
7. Kobelt G, Berg J, Lindgren P, et al: Costs and quality of life of multiple sclerosis in Germany. Eur J Health Econ 2006; 7 (Suppl 2): S34-S44
8. Kobelt G, Lindgren P, Smala A, et al: Cost and quality of life in multiple sclerosis. An observational study in Germany. Health Econom Prevent Care 2001; 2: 60-68
9. Kurtzke JF: Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 1444-1452
10. Lo AC, Hadjimichael O, Vollmer TL: Treatment patterns of multiple sclerosis patients: a comparison of veterans and non-veterans using the NARCOMS registry. Mult Scler 2005; 11: 33-40
11. Marrie RA, Cutter G, Tyry T, Hadjimichael O, Campagnolo D, Vollmer T: Changes in the ascertainment of multiple sclerosis. Neurology 2005; 65: 1066-1070
12. McDonald WI, Compston A, Edan G, et al: Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001; 50: 121-127
13. Multiple Sklerose Therapie Konsensus Gruppe: Immunmodulatorische Stufentherapie der multiplen Sklerose. Nervenarzt 1999; 70: 371-386
14. Multiple Sklerose Therapie Konsensus Gruppe: Immunmodulatorische Stufentherapie der multiplen Sklerose. 1. Ergänzung: Dezember 2000. Nervenarzt 2001; 72: 150-157
15. Multiple Sklerose Therapie Konsensus Gruppe: Immunmodulatorische Stufentherapie der multiplen Sklerose. Neue Aspekte und praktische Umsetzung, März 2002. Nervenarzt 2002; 73: 556-563
16. Multiple Sklerose Therapie Konsensus Gruppe, Rieckmann P: Immunmodulatorische Stufentherapie der Multiplen Sklerose: Update September 2006. Nervenarzt 2006; 77: 1506-1518
17. O'Connor RJ, Cano SJ, Torrenta L, Thompson AJ, Playford ED: Factors influencing work retention for people with multiple sclerosis: cross-sectional studies using qualitative and quantitative methods. J Neurol 2005; 252: 892-896
18. Papathanasopoulos PG, Nikolakopoulou A, Scolding N: Disclosing the diagnosis of multiple sclerosis. J Neurol 2005; 252: 1307-1309
19. Pette M, Eulitz M: Das Multiple-Sklerose-Dokumentationssystem MSDS. Diskussionsgrundlage für einen Dokumentationsstandard Multiple Sklerose? Nervenarzt 2002; 73: 144-148
20. Pittock SJ, Mayr WT, McClelland RL, et al: Disability profile of MS did not change over 10 years in a population-based prevalence cohort. Neurology 2004; 62: 601-606
21. Pittock SJ, Mayr WT, McClelland RL, et al: Change in MS-related disability in a population-based cohort: a 10-year follow-up study. Neurology 2004; 62: 51-59
22. Polman CH, Reingold SC, Edan G, et al: Diagnostic criteria for multiple sclerosis. 2005 revisions to the »McDonald criteria«. Ann Neurol 2005; 58: 840-846
23. Rieckmann P, Toyka KV, Multiple Sklerose Therapie Konsensus Gruppe: Diagnostik und Therapie der Multiplen Sklerose. In: Kommission »Leitlinien« der Deutschen Gesellschaft für Neurologie (Hrsg): Leitlinien für Diagnostik und Therapie in der Neurologie. Georg Thieme Verlag, Stuttgart New York 2005; 298-316
24. Rodriguez M, Siva A, Ward J, Stolp Smith K, O'Brien P, Kurland L: Impairment, disability, and handicap in multiple sclerosis: a population-based study in Olmsted County, Minnesota. Neurology 1994; 44: 28-33
25. Schröder M: MUSIS 2.0 - Multiple Sclerosis Information System: An easy-to-use-database to improve the care of patients with multiple sclerosis. Mult Scler 1999; 5: 299-301
26. Smith MM, Arnett PA: Factors related to employment status changes in individuals with multiple sclerosis. Mult Scler 2005; 11: 602-609
27. Tremlett H, Paty D, Devonshire V: Disability progression in multiple sclerosis is slower than previously reported. Neurology 2006; 66: 172-177
28. Weinshenker BG, Bass B, Rice GP, et al: The natural history of multiple sclerosis: a geographically based study. 1. Clinical course and disability. Brain 1989; 112: 133-146
29. Weinshenker BG, Bass B, Rice GP, et al: The natural history of multiple sclerosis: a geographically based study. 2. Predictive value of the early clinical course. Brain 1989; 112: 1419-1428